Other languages Avecho Biotechnology Limited

Equities

AVE

AU0000047441

Market Closed - Australian S.E. Other stock markets 02:10:55 2024-04-23 am EDT			5-day change	1st Jan Change
0.005 ^AUD	+25.00%		+25.00%	+42.86%

Mar. 25	Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial	MT
Mar. 14	Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug	Mar. 14
Avecho Biotechnology Secures Ethics Clearance for Phase Three Insomnia Trial	Mar. 07
Avecho Biotechnology Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29
Avecho Biotechnology Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31
Avecho Biotechnology Signs Licensing Deal with Arthur Group for Development of Cancer Drugs	23-05-22
Avecho Biotechnology Raises AU$2 Million Via Entitlement Offer; Shares Slip 20%	23-05-08
Avecho Biotechnology Conducts Entitlement Offer to Raise $11 Million to Fund Pivotal Phase Iii Clinical Trial	23-04-02
Avecho Biotechnology Limited Auditor Raises 'Going Concern' Doubt	23-03-14
Avecho Biotechnology Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27
Avecho Biotechnology Expands Research Partnership for Cannabidiol Medication	23-02-22
Avecho Biotechnology Limited Announces Ongoing Collaboration with Lambert Initiative	23-02-21
Athenex Pharmaceutical Division Submits Avecho's Vitamin K Injection to US FDA	23-01-12
Athenex Submits Avecho's Phytonadione to FDA Pre-IND	23-01-11
Avecho Biotechnology Secures Ethics Approval for Phase 3 Insomnia Trial	22-12-22
Avecho Biotechnology Limited Receives Ethics Approval for its Pivotal Phase III Clinical Trial Testing its Oral CBD Softgel Capsule for Insomnia	22-12-21
Avecho Biotechnology Signs Development Deal for TPM-enhanced Ibuprofen Gel for US market; Shares Up 10%	22-12-20
Avecho Biotechnology Limited Signs Development Agreement with Perrigo Company plc	22-12-19
Avecho Biotechnology Limited Announces Interim Results from Comparative Pharmacokinetic Studies Conducted in the Uk	22-09-18
Avecho Biotechnology Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-28
Avecho Biotechnology Validates Efficacy of CBD Topical Gel Product in Hand Osteoarthritis Study; Shares Jump 8%	22-03-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Avecho Biotechnology Limited

Equities

AVE

AU0000047441

Other languages

Filters